View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

CStone Pharmaceuticals: 2 directors

A director at CStone Pharmaceuticals bought 2,687,940 shares at 0.870HKD and the significance rating of the trade was 85/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

 PRESS RELEASE

Transocean Ltd. Announces Results of Tender Offers

Transocean Ltd. Announces Results of Tender Offers STEINHAUSEN, Switzerland, April 18, 2024 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) announced today on behalf of Transocean Inc., its wholly-owned subsidiary (the “Company” and, together with Transocean Ltd., “Transocean”), the results of the Company’s previously announced tender offers to purchase for cash (collectively, the “Offers” and each, an “Offer”) any and all of its outstanding 11.50% Senior Guaranteed Notes due 2027 (the “2027 Super Priority Guaranteed Notes”) and 7.25% Senior Notes due 2025 (the “2025 Priority Guaranteed N...

 PRESS RELEASE

EQS-News: MGI – Media and Games Invest SE gibt Veröffentlichung seines...

EQS-News: MGI - Media and Games Invest SE / Schlagwort(e): Jahresbericht MGI – Media and Games Invest SE gibt Veröffentlichung seines Geschäfts- sowie seines Nachhaltigkeitsberichts für das Jahr 2023 bekannt 18.04.2024 / 13:15 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 18. April 2024 (08:10 CEST) – MGI - Media and Games Invest SE („MGI“ oder das „Unternehmen“, ISIN: SE0018538068; Kürzel M8G; Nasdaq First North Premier Growth Market und Segment ‚Scale’ der Börse Frankfurt) hat seinen Geschäfts- sowie den Nachhaltigkeitsbericht für...

 PRESS RELEASE

Redfin Report: Nearly Half of Biden Voters Want to Live in Place Where...

SEATTLE--(BUSINESS WIRE)-- (NASDAQ: RDFN) —Nearly half (46.8%) of U.S. homeowners and renters who plan to vote for Joe Biden in the upcoming presidential election want to live in a place where recreational weed is legal, compared to 12.4% of U.S residents who plan to vote for Donald Trump. That’s according to a new from Redfin (), the technology-powered real estate brokerage. The data in this report is from a Redfin-commissioned survey conducted by Qualtrics in February 2024. The nationally representative survey was fielded to 2,995 U.S. homeowners and renters, of whom 1,162 said they plan ...

FIMA Research
  • FIMA Research

Fima Daily Insight 18 April 2024

Please find enclosed our daily market report.Market CommentCroatia CIAK takes over LKQ's Slovenian, Bosnian units Croatia’s annual inflation flat at 4.1% YoY in March IMF raises Croatia's 2024 GDP growth f'cast HDZ wins 61 seats, unofficial election results show Slovenia Telekom Slovenije not to share 2023 profit for now IMF lowers GDP growth expectations for Slovenia to 2% Romania Transelectrica puts out a tender for the construction of a new 400 kV power line Nuclearelectri...

 PRESS RELEASE

JD.com Files Its Annual Report on Form 20-F

JD.com Files Its Annual Report on Form 20-F BEIJING, April 18, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission on April 18, 2024 U.S. Eastern Time. The annual report can be accessed on the Company’s investor relations website at The Company will provide a copy of its annual report containing the ...

 PRESS RELEASE

GenSight Biologics met à disposition son Document d’Enregistrement Uni...

PARIS--(BUSINESS WIRE)-- Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurodégénératives de la rétine et du système nerveux central, annonce aujourd’hui avoir déposé son document d’enregistrement universel (URD) 2023 en langue anglaise auprès de l’Autorité des Marchés Financiers (AMF) sous le numéro D.24-0299. Le document d’enregistrement universel inclut notamment : le rapport financier annuel 2023 ; le rappo...

 PRESS RELEASE

GenSight Biologics Announces the Filing of its 2023 Universal Registra...

PARIS--(BUSINESS WIRE)-- Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the filing of its 2023 Universal Registration Document (URD) in English with the French market authority (Autorités des Marchés Financiers, or AMF) under the reference D.24-0299. The universal registration document notably includes: the 2023 annual financial report; the management report; ...

 PRESS RELEASE

Edwards Lifesciences to Host Earnings Conference Call on April 25, 202...

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at . About Edwards Lifesciences Edwards Lifesciences, is the global leader of patient-focused innovations for structural heart d...

 PRESS RELEASE

EQS-News: 2G Energy AG steigert Auftragseingang im 1. Quartal um 26%

EQS-News: 2G Energy AG / Schlagwort(e): Auftragseingänge/Dividende 2G Energy AG steigert Auftragseingang im 1. Quartal um 26% 18.04.2024 / 13:04 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 2G Energy AG steigert Auftragseingang im 1. Quartal um 26% Auftragseingang erreicht 51,7 Mio. Euro (Vj.: 41,0 Mio. Euro) US-Markt überwindet Zurückhaltung und zeigt spürbares Wachstum (10,1 Mio. Euro; Vj.: 2,6 Mio. Euro) 2G verkauft in Deutschland die erste BHKW-Wärmepumpen-Kombination Vorstand und Aufsichtsrat schlagen eine Dividendenerhöhu...

 PRESS RELEASE

EQS-News: 2G Energy AG boosts order intake by 26% in 1st quarter

EQS-News: 2G Energy AG / Key word(s): Incoming Orders/Dividend 2G Energy AG boosts order intake by 26% in 1st quarter 18.04.2024 / 13:04 CET/CEST The issuer is solely responsible for the content of this announcement. 2G Energy AG boosts order intake by 26% in 1st quarter Orders reach EUR 51.7 million (previous year: EUR 41.0 million) US market overcomes caution and shows significant growth (EUR 10.1 million; previous year: EUR 2.6 million) 2G sells its first CHP/heat pump combination in Germany Management and Supervisory boards propose a dividend increase of 21% to EU...

Sun Hung Kai Properties Ltd: 1 director

A director at Sun Hung Kai Properties Ltd bought 601,500 shares at 69.841HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

Tongcheng Travel Holdings Limited: 1 director

A director at Tongcheng Travel Holdings Limited sold 360,000 shares at 22.084HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...

Moody's Ratings corrects the ratings on certain bonds issued by Yuzhou...

Moody's Ratings (Moody's) has corrected the ratings on the Yuzhou Group Holdings Company Limited's USD bonds due February 4, 2023 (ISIN XS1945941786), USD bonds due October 25, 2023 (ISIN XS1508493498), USD bonds due October 25, 2023 (ISIN XS1508493498), USD bonds due February 26, 2024 (ISIN XS19549...

 PRESS RELEASE

The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discus...

The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results. Shareholders and interested participants may listen to a live br...

 PRESS RELEASE

EQS-News: CureVac veröffentlicht am 24. April 2024 Finanzergebnisse de...

Emittent / Herausgeber: CureVac / Schlagwort(e): Sonstiges CureVac veröffentlicht am 24. April 2024 Finanzergebnisse des vierten Quartals sowie des Gesamtjahres 2023 und informiert über seine Geschäftsentwicklung 18.04.2024 / 13:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CureVac veröffentlicht am 24. April 2024 Finanzergebnisse des vierten Quartals sowie des Gesamtjahres 2023 und informiert über seine Geschäftsentwicklung  TÜBINGEN, Germany/BOSTON, USA – 18. April 2024 – CureVac N.V. (Nasdaq: CVAC), ein biopharmazeutisches U...

 PRESS RELEASE

EQS-News: CureVac to Report Fourth Quarter and Full-Year 2023 Financia...

Issuer: CureVac / Key word(s): Miscellaneous CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024 18.04.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024  TÜBINGEN, Germany/BOSTON, USA – April 18, 2024 – CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“m...

 PRESS RELEASE

Mawson Infrastructure Group Inc. Announces Monthly Operational Update ...

Mawson Infrastructure Group Inc. Announces Monthly Operational Update for March 2024 Total Revenue Doubled with 100% Y/Y Growth from March of last year March Self-Mining Business Revenue up 182% Y/Y March Co-Location Business Revenue up 54% Y/Y March Total Revenue of about $5.44 million MIDLAND, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure company, announced today its unaudited business and operational update for March 2024. Rahul Mewawalla, CEO and President, commented, “We are very plea...

 PRESS RELEASE

SpringWorks Therapeutics to Report First Quarter 2024 Financial Result...

SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024 STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that it will host a live conference call and webcast at 8:30 a.m. E.T. on Thursday, May 2, 2024 to report its first quarter financial results and discuss recent business updates. To join the live webcast and view the corresponding slides, please click . To access the live call by phone, please p...

 PRESS RELEASE

Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dress...

Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention   Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon oc...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch